Evidence map›Paper›PMID 24626998›Full record

Trial reportJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2014

Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.

Jacek Kowalczyk, Radoslaw Lenarczyk, Oskar Kowalski, Tomasz Podolecki, Pawel Francuz, Patrycja Pruszkowska-Skrzep, Mariola Szulik, Michal Mazurek, Ewa Jedrzejczyk-Patej, Beata Sredniawa and 2 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Feasibility, safety and outcomes of contrast-free cardiac resynchronisation therapy device implantation: a retrospective cohort comparison.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  3. Article
  4. Three-dimensional mapping in cardiac implantable electronic device - a feasible and effective alternative to fluoroscopy.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. End Points for Clinical Trials in Acute Kidney Injury.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2017
    Article
  10. Article
  11. Non-contrast cardiac resynchronization therapy implantation is feasible in case of renal insufficiency.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jacek KowalczykDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Diseases, Medical University of Silesia, ul. Curie-Sklodowskiej 9, Zabrze, Poland, jacekmed@yahoo.com.
Radoslaw Lenarczyk
Oskar Kowalski
Tomasz Podolecki
Pawel Francuz
Patrycja Pruszkowska-Skrzep
Mariola Szulik
Michal Mazurek
Ewa Jedrzejczyk-Patej
Beata Sredniawa
Zbigniew Kalarus
Triple-Site Versus Standard Cardiac Resynchronization Trial (TRUST CRT) Investigators
Medical University of Silesia · PLSilesian Center for Heart Disease · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBecause data on contrast-induced acute kidney injury (CI-AKI) in patients undergoing cardiac resynchronization therapy (CRT-D) are scarce, we aimed to assess the incidence, natural course and prognostic importance of this syndrome in CRT recipients.

methodsStudy population consisted of 100 consecutive patients enrolled into the Triple Site Versus Standard Cardiac Resynchronization (TRUST CRT) trial, who were treated with CRT-D. Two patients were excluded up to 3 months after randomization and not analysed further. CI-AKI was defined as a rise in serum creatinine of at least 26.5 μmol/L (0.3 mg/dL) within 48 h after contrast exposure, or at least 50% increase from the baseline value during index hospital stay with CRT-D implantation according to KDIGO Clinical Practice Guideline for Acute Kidney Injury.

resultsAmong 98 subjects of TRUST CRT trial, 10 patients (10.2%) developed CI-AKI after CRT-D implantation. In patients with glomerular filtration rate (GFR) <60 mL/min/1.73 m(2) on admission, the incidence of CI-AKI was almost twofold (15.4%) higher than in subjects with GFR ≥60 (8.3%). CRT-D recipients with CI-AKI had significantly higher mortality rate (50.0%) compared to those without CI-AKI (17.0%) during 30 months of follow-up (logrank p = 0.012). Multivariate Cox regression analysis showed CI-AKI as significant and independent risk factor for death in CRT-D recipients (hazard ratio 5.71; 95% CI 5.16-6.26; p = 0.001).

conclusionsContrast-induced acute kidney injury is a serious and frequent procedural complication of CRT-D implantation with a significant negative influence on long-term survival. The results suggest that clinical evaluation regarding renal function should be considered in CRT-D recipients, both before and after device implantation.

Indexed as

Cardiac Resynchronization Therapy DevicesDefibrillators, ImplantableAcute Kidney InjuryAdultAgedAged, 80 and overCardiac Resynchronization TherapyContrast MediaCreatinineFemaleGlomerular Filtration RateHumansIncidenceMaleMiddle AgedPrognosisContrast MediaCreatinine

Identifiers

PMID24626998
PMCPMC4062808
OpenAlexW2148238450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.